✨ Free AI Report
Paul Hartmann AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Paul Hartmann AG
Company Research

Paul Hartmann AG: Business Overview, Financials & Competitive Analysis

Paul Hartmann AG scores 7/10 on the AskCyborg Cyborg Score (Strong). A well-positioned healthcare company with demographic tailwinds, strong earnings recovery, and diversified product portfolio across essential care segments. In 2024, revenue reached €2.43 billion with earnings increasing 281.58%, demonstrating strong operational improvement and market demand. The company's established brand portfolio, global distribution, and focus on essential healthcare products provide.

What is Paul Hartmann AG's industry? Paul Hartmann AG (paulhartmann.de) operates in Medical and Healthcare Products Manufacturing - Orthopedic, Prosthetic, and Surgical Appliances and Supplies. AskCyborg classifies Paul Hartmann AG under Medical and Healthcare Products Manufacturing - Orthopedic, Prosthetic, and Surgical Appliances and Supplies in its company registry.

Paul Hartmann AG manufactures and sells medical and care products globally across three segments: Incontinence Management, Wound Care, and Infection Management. The company is a leading provider of hygienic products a...

7/ 10Strong

Cyborg Score thesis

A well-positioned healthcare company with demographic tailwinds, strong earnings recovery, and diversified product portfolio...

Read the full analyst-debate transcript →
Industry Medical and Healthcare Products Manufacturing - Orthopedic, Prosthetic, and Surgical Appliances and Supplies
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 21, 2026
AI-Verified Research
30+ Page Report

Get the Latest Paul Hartmann AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Paul Hartmann AG

AskCyborg analysts argue the bull and bear cases for Paul Hartmann AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Paul Hartmann AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Paul Hartmann AG Overview

Pro stress-test →

Paul Hartmann AG manufactures and sells medical and care products globally across three segments: Incontinence Management, Wound Care, and Infection Management. The company is a leading provider of hygienic products and medical solutions with recognized brands including MoliCare, Sterillium, Zetuvit, and Veroval.

Strategic Profile

Pro stress-test →

Founded in 1818 and headquartered in Heidenheim, Germany, Paul Hartmann holds a strong competitive position in the aging-population-driven healthcare sector. The company's diversified product portfolio across wound management, incontinence care, and infection prevention positions it well in essential healthcare markets with recurring demand.

Competitive Landscape

Pro stress-test →

Paul Hartmann competes in the fragmented global medical and hygiene products sector alongside companies like Coloplast, Hollister Incorporated, and B. Braun. The company differentiates through its heritage brand strength, integrated product solutions across care segments, and strong European healthcare relationships.

Industry Context

Paul Hartmann AG operates in Medical and Healthcare Products Manufacturing - Orthopedic, Prosthetic, and Surgical Appliances and Supplies.

Key facts

Founded: 1818 · Headquarters: Heidenheim, Germany · Revenue: €2.43B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Paul Hartmann AG.

  • 2024 revenue of €2.43 billion represents a 2.46% increase year-over-year
  • Three-segment structure (Incontinence, Wound Care, Infection Management) provides diversified revenue streams
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2025Q4 2025 Earnings Release scheduled
  • 2024Significant earnings improvement with 281.58% increase
  • +1 moreTrack every material event for Paul Hartmann AG as it happens. Explore monitoring →
Get alerted when Paul Hartmann AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Incontinence and Wound Care ProductsSpecialized medical devices for ostomy, continence, and wound care→Medical and Surgical SuppliesHealthcare products including continence care and wound care→Medical TechnologyPharmaceuticals and medical device manufacturer→

Compare Paul Hartmann AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Paul Hartmann AG operates in Medical and Healthcare Products Manufacturing - Orthopedic, Prosthetic, and Surgical Appliances and Supplies. See how the rest of the sector scores on the Cyborg framework.

Browse Medical and Healthcare Products Manufacturing - Orthopedic, Prosthetic, and Surgical Appliances and Supplies research →
NEW · MCP server

Ask your AI assistant about Paul Hartmann AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Paul Hartmann AG and its top competitor on Cyborg Score”
“What did Paul Hartmann AG do this quarter?”
“Is Paul Hartmann AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Paul Hartmann AG do?+
Paul Hartmann AG manufactures and sells medical and care products globally across three segments: Incontinence Management, Wound Care, and Infection Management. The company is a leading provider of hygienic products a...
What is Paul Hartmann AG's Cyborg Score?+
Paul Hartmann AG has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Paul Hartmann AG's main competitors?+
Named competitors include Incontinence and Wound Care Products, Medical and Surgical Supplies, Medical Technology. The full competitive landscape is in the AskCyborg report.
How can I get the full Paul Hartmann AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Paul Hartmann AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Paul Hartmann AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.